Laquinimod Study in Active Crohn's Disease
- Study Title
- Laquinimod Phase IIa Study in Active Crohn's Disease
- Teva Identifier
- CD-LAQ-201
- ClinicalTrials.gov Identifier
- NCT00737932
- Study Status
- Completed
- Trial Condition(s)
- Crohn's Disease
- Interventions
- Drug: Laquinimod | Other: placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 75 Years
- Trial Duration
- 05/01/2010 - 12/01/2011
- Phase
- Phase 2
